ArticlePloS one2025
Mediating role of inflammatory markers in the relationship between cotinine levels and total bone mineral density.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study investigates the relationship between smoking and total BMD and examines the mediating role of inflammatory markers in this relationship.
methodIn total, 22,022 participants were included in this study, based on data from the National Health and Nutrition Examination Survey for the periods 2001-2006 and 2011-2018. Weighted linear regression models and restricted cubic splines(RCS) were leveraged to examine the linear or nonlinear relationship between serum cotinine levels and total BMD. Additionally, mediation analysis was leveraged to appraise the potential mediating effects of inflammatory markers, such as lymphocytes, monocytes, neutrophils, and platelets, in the relationship between cotinine and total BMD.
resultsAfter fully adjusting for all covariates, an increase of one unit in cotinine corresponded to a 0.00022 g/cm2 decrease in total BMD (Beta = -0.00022, 95% CI: -0.0003 ~ -0.0000, P = 0.0069). The RCS analysis indicated an "n-shaped" relationship between cotinine and total BMD (P-nonlinear = 0.0069). According to the mediation analysis, monocytes and neutrophils acted as mediators in the relationship between cotinine and total BMD, with mediation effects accounting for 19.8% and 19.6%, respectively.
conclusionsSmoking serves as a risk factor for reduced BMD, and the impact on BMD is partially mediated by inflammatory markers such as monocytes and neutrophils. Platelets can moderate the effect of cotinine on total BMD to some extent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.